Cancer Treatment Today

Skin cancers, especially squamous cell cancers,  are very common after solid organ transplantation (SOTR). The incidence of skin cancer varies from country to country. Early reports were ranging from 10 to 40% at 10 and 20 years after transplantation. This incidence is higher in sunny Australia, 45 and 70% at 10 and 20 years, respectively, after the transplantation. Cutaneous premalignant and malignant epithelial lesions (carcinoma) are the most

Rosacea is a skin disorder that is characterized by persistent erythema, telangiectasias and acute episodes of edema, papules, and pustules, and easy flushing. Avoidance of excessive sunlight and extreme temperatures is typically recommended. Medical management is aimed only at the inflammatory papules and pustules and the erythema that surrounds them. Treatment is based on topical, or in severe and refractory cases, on orla antibiotics and Accutane.

Carcinomas of the eccrine sweat gland represent a rare group of tumors with potential for local destruction and metastasis. High recurrence rates have been reported following conventional surgical excision. There are case reports of detection of this entity by PET but no larger series. Sensitivity, specificity and accuracy of PET for this cancer are not known. Because of the rarity of these tumors, specific guidelines for the investigation of possible

Metastatic basal cell carcinomais very rare. THE REPORTED incidence of metastatic basal cell carcinoma (MBCC) ranges from 0.003% to 0.55%. The range is in part due to the lack of accurate data for the incidence of basal cell carcinoma (BCC), which has an estimated incidence of 900 000 to 1 200 000 in the United States, but is excluded from traditional national cancer registries, such as Surveillance, Epidemiology and End Results. While BCC is a slow-growing,